Lexington Biosciences Inc. (LXGTF)

[Georgie21]

Wait until HeartSentry hits the commercial market. They are finishing up their clinical trials now and still need FDA approval. You can't judge a company's business structure or value when their biggest revenue generator is in these premature stages.

If HeartSentry was approved and had a few quarters of sales under their belt and the stock dropped significantly,I'd be concerned and you could argue it's a falling knife...HOWEVER...Lexington is not there yet. And because of that (HeartSentry-their soon to be biggest revenue generator- is in the process of being approved) you can't look at this company and say something is going wrong. They have 15 years of R&D sank into this...I'm pretty sure they know what their doing, hence why the next couple of months will be extremely exciting as an investor of LXGTF and more importantly it will be exciting for healthcare as millions of people will benefit from the functionality of this device so they can better assess their CV health.